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Background. Olfactory receptors (ORs) are the largest gene family in mammalian genomes. Since nearly all OR genes are
orphan receptors, inference of functional similarity or differences between odorant receptors typically relies on sequence
comparisons. Based on the alignment of entire coding region sequence, OR genes are classified into families and subfamilies,
a classification that is believed to be a proxy for OR gene functional variability. However, the assumption that overall protein
sequence diversity is a good proxy for functional properties is untested. Methodology. Here, we propose an alternative
sequence-based approach to infer the similarities and differences in OR binding capacity. Our approach is based on similarities
and differences in the predicted binding pockets of OR genes, rather than on the entire OR coding region. Conclusions.
Interestingly, our approach yields markedly different results compared to the analysis based on the entire OR coding-regions.
While neither approach can be tested at this time, the discrepancy between the two calls into question the assumption that
the current classification reliably reflects OR gene functional variability.
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INTRODUCTION
Olfactory receptor (OR) genes, the largest gene family in
mammalian genomes, constitute the basis for the sense of smell
[1–3]. Based on their full length protein sequence similarity,
mammalian OR genes are divided into two classes, 17 families and
,250 subfamilies [4]. OR genes from the same subfamily are
defined as sharing 60% or more of their overall amino acid
sequence. Class I genes are closely related to OR genes found in
fish and are hence referred to as ‘fish like’ [5], while class II OR
genes are specific to terrestrials [3]; but see [6].
Recently, the complete OR gene repertoires of a number of
mammalian species became available, permitting interspecies
comparisons of complete OR gene repertoires [3,7–10]. Such
inter-species comparisons may increase our understanding of the
similarities and differences between the sense of smell of different
species. Humans, for example, have roughly 900 OR genes
[3,11,12], but 54% of them carry one or more coding region
disruptions and therefore are annotated as pseudogenes. In
contrast, the mouse OR gene repertoire is ,30% larger than
that of man [7,13,14], but contains only 20% pseudogenes. Thus,
the mouse putative functional OR gene repertoire is more than
three times larger than that of humans [15]. Similarly low
proportions of OR pseudogenes were found in dogs and rats
[8,9,16]. In fact, it appears that humans have been accumulating
OR pseudogenes faster than other primates [17–19], and as
a result, have fewer intact (and putatively functional) OR genes,
even when compared with chimpanzee, our closest living
evolutionary relative [10].
However, nearly all mammalian OR genes are orphan
receptors, as very few ligand (odorant) – receptor interactions
have been demonstrated for OR genes [20]. Indeed, direct inter-
species functional studies are extremely demanding and hence rare
[21]. As a proxy for functional variability, similarities and
differences between the protein sequence of OR genes are often
used [7,14]. In this approach, it is assumed that when orthologous
OR genes are identical in sequence, both species maintain the
same olfactory capability. More difficult is the interpretation of
sequence differences between orthologous genes. To date, OR genes
have been thought to have a similar function so long as they were
classified into the same subfamily based on the full length of the
OR protein [4,7,14]. This assumption remains untested.
Differences in specific binding properties are expected to be
affected primarily by changes in the receptor’s binding site(s) [22–
24]. Hence, sequence similarity in binding sites, rather than in the
entire protein, may be a more reliable predictor of functional
similarity. To examine this possibility, we assess functional
variability across OR gene repertoires of two species, mouse and
human, by considering only the putative OR protein binding site
[25]. We assume that OR genes with identical binding sites have
the same binding properties and use Grantham’s amino acid
property scales [26] to model functional differences among
binding sites. We note that the assumption underlying our
approach is also not tested. Moreover, at this time we cannot
assess whether our analysis provides more accurate functional
inference than the commonly used analysis based on the entire
OR coding region. Instead, we propose our approach as a second,
sensible solution to a problem that to date has only been addressed
using only a single type of analysis. Interestingly, we find that the
two approaches yield markedly different results, with potentially
important implications for the interpretation of OR gene families.
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Representation of the odorant space
The species’ odorant space can be defined as the collection of all
odorants that a species is capable of detecting as well as their
detection thresholds. Direct mapping of a species’ odorant space
could be achieved by either in vivo testing of the detection threshold
for all possible odorants, or by identifying the binding affinity
properties of all functional OR genes in vitro. Currently, high
throughput data of this type do not exist.
Instead, we take an indirect route to infer the odorant space of
human and mouse by mapping the chemical distances between the
putative specificity determining residues (SDRs) [25] of all OR
genes. These residues were predicted based on protein sequence
analysis and are supported by experimental results (see methods).
In particular, a functional role for most of these putative SDRs was
confirmed by a recent OR protein functional study (Kristin
Schmiedeberg, Elena Shirokova, Hans-Peter Weber, Jens Reden,
Thomas Hummel, Boris Schilling, Wolfgang Meyerhof, and
Dietmar Krautwurst; personal communication). Henceforth, we
refer to the SDR residues as the putative binding site.
For our inter-species comparison of OR repertoire variability,
we use the entire human and mouse OR intact gene repertoires,
the only two species for which we have well characterized
repertoires from finished genomic sequence (the dog OR
repertoire is not yet fully described [8] and the draft of the
chimpanzee genome has relatively low coverage for this type of
analysis [10]). We use previously published multiple alignment of
OR genes from human and mouse [25] in order to identify the
putative binding sites of all OR proteins. To estimate distances
between binding sites, we construct a distance matrix for the 22
amino acid residues of each binding site, utilizing Grantham
indices [26]. We visualize this distance matrix in two and/or three
dimensional space by using the isomap algorithm [27,28] for
geodesic mapping (see methods). This approach assumes that
proximity in binding sites reflects similarity in binding properties
(i.e., that the ORs bind related odorants with similar binding
affinity). Conversely, distant binding sites are assumed to have
highly distinct binding properties. This set of assumptions has also
been made when inferring functional variability from phylogenetic
tree distances between OR genes based on the entire protein
sequence (e.g., [14]).
The human and mouse odorant spaces.
We superimpose two-dimensional representations of the human
and mouse odorant spaces to compare the relative space coverage.
As can be seen in figure 1, the odorant spaces of human and
mouse largely overlap. However, even at low resolution (a high
resolution 3D map of the entire data is available as supplementary
material at http://senselab.med.yale.edu/senselab/ORDB/ord-
b_ent.html), regions of the map enriched in ORs from only one of
the species are readily apparent (e.g. regions a–d in Figure 1). We
note that, as expected, representing the human and mouse OR
repertoires using randomly selected groups of 22 residues of the
OR protein yields vastly different results than those shown here
(Figure S1).
To identify groups of OR genes with highly similar binding
sites, we perform a clustering analysis (see methods). This yields
258 clusters, 64 of which contained only a single gene. Of the 194
clusters with more than one gene, six (P [of observing as many or
more clusters]=0.34) and 104 (P=0.01) have greater than 70% of
Figure 1. 2D representation of the human (red) and mouse (blue) odorant spaces. Map regions with an over-representation of binding sites from
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find 41 clusters only in one of the two species (5 human-specific
(P=0.03) and 36 mouse-specific (P=0.09). Interestingly, these do
not correspond to the classification to OR gene subfamilies. In
fact, inspection of a full-length protein sequence phylogenetic tree
of OR genes reveals that clusters of OR genes with highly similar
binding sites in our analysis are not often monophyletic, and often
are not even in close proximity with one another (as illustrated in
Figure 2A, B). Specifically, only six of the 41 OR clusters specific
to one species consist entirely of genes that form a monophyletic
clade in the phylogenetic tree based on the entire protein
sequences of human and mouse OR genes.
Clustering analysis and the case of isovaleric acid
Our analysis suggests an explanation of the apparent contradiction
between the sensitivity of mice and humans to isovaleric acid (IVA)
and the lack of IVA OR orthologs in humans when full length
sequences are compared. Specifically, the genomic regions
responsible for specific anosmia to Iva in the mouse were
identified [29] and, following the classification of the complete
mouse OR gene repertoire, 12 intact OR genes (as well as two OR
pseudogene with more than two coding region disruptions) were
mapped to these regions [7]. Based on full-length protein sequence
analysis, the 12 intact OR genes were classified into two small
subfamilies that were found to be specific to mouse [7]. Based on
Figure 2. A. 3D representation of the human (red) and mouse (blue) odorant spaces. Shown in dark green is a mouse-specific cluster (consisting of
MOR232-2, MOR232-5, MOR233-1, MOR233-7, MOR235-1). B. A phylogenetic tree based on the full protein sequence that includes all five genes (dark
green) in the mouse specific cluster shown in A. The five genes do not form a monophyletic clade, but instead are interspersed among human (red)
and other mouse (blue) genes.
doi:10.1371/journal.pone.0000682.g002
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similarity, the lack of human OR gene orthologs to either of the
two subfamilies would indicate that humans cannot detect Iva.
However, O’Connell et al. [30] reported that humans can detect
Iva at relatively low threshold concentration. Using the putative
binding sites to cluster OR genes helps resolve this apparent
contradiction: By our approach, the 12 mouse OR genes that
confer the ability to detect Iva cannot be clustered without
including human OR genes i.e., genes from the two species are
interspersed (Figure 3). Thus, consideration of only the binding
sites suggests that genes with similar binding properties are present
in both species and that both humans and mice can detect Iva
(possibly with similar capacity), in agreement with the finding of
O’Connell et al.
DISCUSSION
To date, the functional variability within and between OR gene
repertoires has been assessed by considering overall protein
similarity [7,14]. However, following gene duplication, the binding
properties of an OR gene (or any receptor) may be modified by
a few changes to the binding site. As a result, full-length protein
sequence phylogenetic analysis captures the evolutionary relation-
ship between different OR genes, but not necessarily the similarity
in binding properties. In other words, recently duplicated OR
genes may be highly similar at the overall protein level, but differ
markedly in their binding capacities due to few changes to their
binding sites. Here, we assess functional variability within OR
gene repertoires by comparing the putative binding sites [25] of all
human and mouse putatively functional OR genes.
We find that the odorant spaces of the two species largely
overlap, but that there is a somewhat larger than expected number
of human-specific clusters of genes with highly similar binding
sites, as well as a highly significant number of mouse-enriched
(.70%) clusters. These clusters of genes do not form mono-
phyletic, species-specific lineages when the entire OR protein
sequences were analyzed. The finding that two sets of assumptions
yield such disparate results is interesting in its own right as it calls
into question the reliability of the standard subfamily-based
classification of OR genes into functional groups.
It also raises the question of how to interpret OR gene clusters.
A single receptor is thought to bind a series of chemically related
odorants, with different affinities associated with each interaction
[31,32]. If so, then, even with fewer functional receptors, humans
may have preferentially retained ORs with broad specificities
(‘generalists’) in order to maintain the ability to detect most
odorants [33]. Alternatively, humans may have kept sets of OR
genes that differ subtly in their binding sites in order to maintain
strong binding affinity for each and every odorant in a group of
chemically related compounds that are important in human
evolution. Our analysis may be able to generate hypotheses to
distinguish between these two possibilities: when a species requires
the ability to detect and discriminate between chemically related
odorants at low concentrations, this pressure should give rise to
a cluster of OR genes with only subtly different binding sites.
Conversely, if a region of the odorant space is represented by only
one (or very few) ORs, this might suggest that most of the related
odorants in that space are detected with low affinity (i.e., only at
high concentration).
Overall, our analysis suggests that the odorant spaces of human
and mouse largely overlap suggesting that, at saturating concen-
trations, both species are able to detect most odorants. In this
respect, our results are consistent with the behavioral findings of
Laska et al. [21]. However, we also find dozens of clusters of
similar binding sites that are exclusive to one species, or nearly so.
We speculate that these clusters reflect differences between human
and mouse with respect to threshold detections of odorants bound
by the OR genes that these clusters contain.
This said, we cannot test our predictions, (or the predictions
based on the commonly used analysis of the entire coding region).
Mapping receptor-odorant interactions has proven to be a chal-
lenging task. Indeed, only a few receptor-odorant interactions have
been reported [32,34,35], and a large number of them relate to
a single gene, OR I7 from rat. While the rat I7-odorant
Figure 3. 2D representation of the human (red) and mouse (blue)
odorant spaces. The ‘Iva mouse OR genes’ (yellow) do not form a single
cluster (A). High resolution 2D representations of map regions I (B) and
II (C) reveal that human OR binding sites are interspersed with the
mouse Iva ORs in both regions.
doi:10.1371/journal.pone.0000682.g003
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different assays [36], most of the other putative receptor-odorant
interactions have not yet been replicated, and were found using
only one assay, often with unclear implications for in-vivo
receptor-odorant interaction. Moreover, some of the reports have
been contradictory. Thus, existing data are neither comprehensive
nor reliable enough to be used for validation of our predictions.
Since neither our approach nor that of using the full coding
sequence can be validated experimentally, it is unclear which
yields more accurate results.
Moreover, our findings are based on the current prediction of
the OR protein SDR, which may change when a validated OR
protein structure is available, or when other residues that
determine the binding specificity are recognized. Clearly, our
results are dependent on the identity of the 22 residues we analyze.
However, our analysis can be easily repeated for a different set of
residues.
In conclusion, our approach can not replace empirical studies of
receptor-odorant interactions, but can help to generate prediction
that can be tested empirically. In particular, as demonstrated for
the case of the IVA, hypotheses generated using our approach may
be quite different from those generated under the widely used
classification approach which is based on the analysis of the entire
OR protein sequence.
METHODS
Prediction of the specificity determining residues
We rely on previous prediction of 22 specificity determining
residues (SDRs) in OR proteins [25]. The assumption underlying
the prediction of these SDRs was that these residues would be
more conserved among orthologs, which are assumed to have
a similar binding spectrum, than among paralogs, which are
assumed to have a divergent binding spectrum. The implementa-
tion of this concept relied solely on protein sequence information.
The same concept has been previously utilized to predict SDRs in
bacterial transcription factors [37] and eukaryotic and eubacterial
protein kinases [38]. In both cases the predictions were consistent
with solved structures as well as experimental results. For OR
proteins, no X-ray crystallographic structure has been determined
and the only report of a mutation affecting specificity [35] is now
in question [39]. Thus, the only validation of the predicted SDRs
utilized information available from homologous GPCRs: In
a homology model based on a high-resolution X-ray crystallo-
graphic structure of rhodopsin [40], the 22 putative SDRs occupy
the region corresponding to the retinal binding site. In addition, 21
of the 22 predicted SDRs correspond to amino acid positions that
were previously associated with ligand-binding in at least one other
GPCR [25].
Multiple sequence alignment of OR proteins
We used the alignment of [25], which contains 1441 protein
sequences (402 and 1039 sequences from human and mouse,
respectively). The alignment was constructed from all human and
mouse OR protein sequences that span the seven putative
transmembrane regions, contain no ambiguous residues, and no
more than two coding region disruptions (in the text, we refer to all
these as ‘intact’ genes). The approach taken in aligning the
sequences was hierarchical in nature, combining automatic
alignment of closely related sequences and the merger of such
small alignments into larger alignments, each containing all the
sequences belonging to a specific OR family. These family
alignments were manually edited in order to ensure the correct
alignment of the transmembrane regions, as well as of other OR
protein motifs (such as an N-glycosylation site). Also, positions
containing a gap in more than half of the members of the family
were edited out. Finally, the family-wise alignments were manually
merged into a single one, containing all 1441 OR sequences [25].
Phylogenetic analysis
A neighbor-joining tree was constructed from the most reliable
positions in the OR multiple sequence alignment (positions
containing fewer than 1% gaps), using ClustalX v1.83 [41]. Trees
were drawn using TreeExplorer (K. Tamura; http://evolgen.biol.
metro-u.ac.jp/TE/TE_man.html).
Mapping of the odorant spaces of human and
mouse
Currently, there are no solved structures of OR proteins. Here, we
rely on a prediction of the putative binding site based on the
premise that orthologous OR genes are likely to have similar
binding sites while the binding sites of paralogous OR genes are
likely to be different [25]. This theoretical prediction is in general
agreement with the empirical results of Katada et al. [42]. We
extracted the 22 residues corresponding to the putative odorant
binding site from each OR sequence in the multiple alignment
[25]. Nine OR genes (human genes: OR9G3P, OR11J2P,
OR2AE1, OR56B4; mouse genes: MOR188-2, MOR126-1,
MOR126-2, MOR176-3, MOR204-25P) were found to contain
a gap within the putative binding site, and were excluded from
subsequent analyses.
Next, we constructed a distance matrix comparing the putative
binding sites of all possible pairs of OR genes. In modeling the
distance between binding sites, we used the Grantham chemical
difference matrix [26]. It has been shown that differences between
disease alleles and wild-type alleles computed using the Grantham
matrix are on average greater than those observed between
putatively neutral polymorphic alleles, as well as inter-species
differences [43]. This suggests that protein distances predicted by
this matrix are functionally relevant.
Wedownloaded from the AAIndex database[44]the three amino
acid scales used in the construction of the Grantham chemical
difference matrix [26], namely aax1:GRAR740101 (Composition),
aax1:GRAR740102 (Polarity), and aax1:GRAR740103 (Volume).
We used these indices to translate the putative binding site of each
OR protein into a 66-dimensional vector. We then computed all
pairwise distances between the vectors, using the standardized
Euclidean distance as the distance measure, i.e., weighting each
coordinate by the inverse of its variance.
In order to to visualize the 66-dimensional space in two- and/or
three-dimensions, we used the Isomap algorithm for geodesic
dimensionality reduction [27]. We downloaded the Isomap
Matlab package from http://isomap.stanford.edu/. We then
applied the IsomapII function (in Matlab/Math Works Inc v7
(R14)) to the previously computed distance matrix, using all
available points as landmarks, and requesting that ten dimensions
be calculated. In order to select the appropriate e value, the
neighborhood size parameter, we applied the tuning methodology
described in [28]. Briefly, in this methodology, the algorithm is run
multiple times, varying only the neighborhood size parameter, and
recording each time the values of two cost- functions: the fraction
of variance in geodesic distance estimates not accounted for by the
Euclidean embedding and the fraction of points not included in
the largest connected component of the neighborhood graph, and
thus not included in the Euclidean embedding. The optimal
neighborhood size is then determined as a tradeoff between these
two cost functions. We found e=14.5 to be the optimal value for
OR Gene Classification
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as well as for the two-dimensional (accounting for 58.1% of the
variance) embeddings. We confirmed the validity of the projection
method by calculating the correlation of the matrix of standard-
ized Euclidean distances based on the 66 dimensions with the




Comparison of the mapping of odorant space
obtained using the SDRs with those obtained using
random sets of OR protein positions
In order to repeat our analysis using random sets of 22 residues,
we used the set of sequence alignments that include only residues
with no gaps as a pool, excluding the 22 SDRs themselves. This
screening step resulted in a pool of 154 residues (of 327 positions in
the original alignment) to choose from. Out of this pool we
randomly chose five sets of positions, each of size 22. We then
repeated the mapping procedure, using these random sets of
positions instead of the SDRs, and reproduced figure 1 for each
random set of residues (Figure S1).
Cluster analysis
We applied agglomerative hierarchical clustering with average
linkage, as implemented in Matlab/Math Works Inc v7 (R14), to
the three-dimensional coordinates obtained from the Isomap
procedure, using Euclidean distances as a distance measure. To
determine the appropriate number of clusters, we utilized the
unrefined L-method [45]. For this purpose, the score for a specific
number of clusters was the distance between the two nearest
clusters (i.e. the clusters that would be merged if we were to
decrease the number of clusters by one). By plotting scores against
the number of clusters we determined the knee of the curve, and
thus the number of optimal clusters, to be 110.
The 110 clusters obtained ranged in size from 1 (singleton
clusters) to 323 ORs. Because of the wide range of cluster sizes, we
decided to re-apply the hierarchical clustering. In order to
determine which clusters would be divided further, we used the
unrefined L-method [45] again, this time plotting cluster size
against cluster rank, where the rank is determined by size. We
found that the knee of the curve corresponded to a cluster of size
46, and, thus, re-applied the hierarchical clustering procedure to
only the seven clusters containing at least 46 OR genes. Our final
analysis yielded 258 clusters, ranging in size from 1 to 29 (mean
size: 5.56).
To test the significance of observing clusters specific to one
species or enriched (.70%) in one species, we took the following
approach: For each group of clusters that are specific or enriched
in one species, containing N clusters of sizes s1$s2$…$sN,w e
randomly permuted the species-assignments 100,000 times, and
counted the number of permutations fulfilling the following
conditions (excluding singletons):
1. M, the number of clusters belonging to class X in the random
permutation, fulfills N#M.
2. Let t1$t2$…$tM be the sizes of the clusters belonging to




Found at: doi:10.1371/journal.pone.0000682.s001 (0.05 MB
DOC)
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